{"id":"W4410916531","doi":"10.1038/s41591-025-03738-z","title":"Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Core Research for Evolutional Science and Technology; Pfizer","keywords":"Bladder cancer; Medicine; Crest; Randomized controlled trial; Cancer; Urothelial cancer; Oncology; Internal medicine; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001377759,0.001068078,0.001467719,0.0002258929,0.0002569163,0.0007729163,0.0005208148,0.0009437131,0.003126926],"category_scores_gemma":[0.0009091798,0.0002727526,0.001928525,0.0002592111,0.0005755361,0.0004880992,0.0003655102,0.002217064,0.000460191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005165674,"about_ca_system_score_gemma":0.001223057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001055055,"about_ca_topic_score_gemma":0.002645639,"domain_scores_codex":[0.9995539,0.0002861142,0.00001711337,0.0000482913,0.00003795846,0.00005649504],"domain_scores_gemma":[0.9996126,0.00008951474,0.00009261422,0.00003358798,0.00003030829,0.0001414581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9510793,0.004998792,0.001027159,0.001048928,0.001337604,0.00007010798,0.00006777095,0.001057461,0.004635879,0.0003016939,0.002476615,0.03189868],"study_design_scores_gemma":[0.8867078,0.1035142,0.00408796,0.00009864243,0.0009219057,0.0001074059,0.00004218037,0.00116625,0.0008026532,0.0003368287,0.002189989,0.00002409433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821216,0.01027598,0.0005641552,0.0008740519,0.0005119923,0.001823933,0.0006911771,0.0001051372,0.003032011],"genre_scores_gemma":[0.9841862,0.004578678,0.001467983,0.001834202,0.0003349771,0.002544012,0.001332431,0.00003040916,0.003691108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003126926,"threshold_uncertainty_score":0.01046062,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01066045220669053,"score_gpt":0.3350979458669067,"score_spread":0.3244374936602161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}